Skip to content

Clinical trials

Phase 3 Kidney Diseases trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Diseases Phase: Phase 3 Country / region: Russia Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20081
20101
20111
20121
20152
20161
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Bayer2
Tanabe Pharma Corporation2
AstraZeneca1
Human Genome Sciences Inc., a GSK Company1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Diseases10
Renal Insufficiency, Chronic5
Carcinoma, Renal Cell2
Diabetes Mellitus, Type 22
Diabetic Nephropathies2
Kidney Neoplasms2
Anemia1
Autoimmune Diseases1
Carcinoma1
Glomerulonephritis1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.